COCH
Envoy Medical Inc.
0.6576$
+0.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 20 | Q1 21 | Q2 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -41.6% | -3.4% | -64.9% | +290.0% | -19.2% | +27.0% | +18.8% | -37.9% | +15.3% | -17.6% | -25.0% | +9.5% | +69.6% | -46.2% | +78.6% | -48.0% | +30.8% | – | |
| – | – | – | – | – | +2.3% | -51.4% | +42.5% | +15.9% | -7.4% | +16.7% | +23.8% | -34.6% | +60.1% | -23.7% | -16.0% | +43.9% | +3.5% | -13.2% | +3.9% | +48.3% | -11.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +30.1% | -31.3% | +54.3% | +33.5% | +11.7% | -14.1% | +65.1% | -22.7% | +9.8% | +6.4% | -10.4% | +11.2% | -9.6% | +8.7% | +68.6% | -20.0% | -14.0% | – | |
| – | – | +10.8% | +178.8% | -78.2% | +3.4% | +20.5% | -45.0% | +207.8% | +34.1% | -44.3% | +193.7% | -29.7% | -24.7% | +6.1% | -16.1% | +28.2% | +13.6% | +18.1% | -34.5% | +17.4% | +8.0% | – | |
| – | +137,742.7% | +10.8% | -10.0% | +76.2% | +19.8% | -14.2% | +58.8% | +32.4% | +19.2% | -25.2% | +101.0% | -27.0% | -2.5% | +3.4% | -9.0% | +11.7% | -0.3% | +12.9% | +12.7% | -9.0% | -6.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | +266.7% | +100.0% | +45.5% | +28.9% | +26.1% | -24.5% | +375.2% | -100.0% | – | – | |
| – | – | – | -1,371.6% | – | – | – | – | – | – | – | -413.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -99.2% | +393.0% | +61.0% | -2.1% | -85.6% | -123.9% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -1,371.6% | – | – | – | – | – | – | – | -413.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -360.3% | – | – | – | – | – | – | – | -404.5% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.